If you are a member of a CF care team

How to refer

1. Step 1

   Review eligibility

   Confirm the person meets the inclusion criteria (PWCF age ≥6, eligible for VTD and intending to take it, and history of neuropsychiatric adverse events or concerns of liver injury on ETI that resulted in a modification or discontinuation of standard ETI dosing. Cannot be currently taking VTD or full, standard dose of ETI.) More information on ClinicalTrials.gov

2. Step 2

   Use CFF Trial Finder

   Locate a participating RETRIAL site through the CFF Trial Finder and contact them to initiate the referral. Main study arms are fully remote and referral can be to any participating site. Optional sub-studies require an in-person visit; choose the closest one.

3. Step 3

   Share medical records

   Once the participant signs a release, provide medical records to the recruiting study site as requested.

Your role as a referring site

• Mental Health Coordinator

  Identify a Mental Health Coordinator at your CF Center responsible for managing mental health alerts (Mental Health arm only).

  • Response to these alerts is part of clinical care, for a population known to have mental health concerns.

• Records release

  Provide the study site with medical records once the release form has been signed.

• Stay in the loop

  The receiving study site will keep you informed.

  • Research survey data (enhanced monitoring reports) will be shared with the referring CF care team after the 28-day and 6-month data collection points, to be used (or not) as the CF care team sees fit.

• CRRSP program

  RETRIAL has been sanctioned for conduct in the TDN. Compensation is available to referring accredited CF care centers through the Clinical Research Referrals Support Program (CRRSP) program.

  • Applications for compensation for the prior calendar year open in December.